To study visual and anatomical outcomes of sequenced combined therapy using intravitreal bevacizumab followed by photodynamic therapy (PDT) in eyes with retinal angiomatous proliferation (RAP). Safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback